RPRX
Royalty Pharma Plc
NASDAQ: RPRX · HEALTHCARE · BIOTECHNOLOGY
$50.09
+1.21% today
Updated 2026-04-30
Market cap
$29.37B
P/E ratio
27.83
P/S ratio
12.35x
EPS (TTM)
$1.78
Dividend yield
1.77%
52W range
$31 – $50
Volume
3.2M
Royalty Pharma Plc (RPRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.85M | $27.60M | $22.60M | $2.96M | $4.46M | $6.06M | $26.83M | $78.98M | $46.94M | $10.82B | $10.48B | $11.37B | $11.37B | $12.45B | $21.10B | $17.52B | $16.81B | $16.38B | $18.22B | $19.62B |
| Cash & equivalents | $1.14M | $1.78M | $19.47M | $1.89M | $2.96M | $4.57M | $24.21M | $75.81M | $46.62M | $1.72B | $1.67B | $1.38B | $1.92B | $246.20M | $1.01B | $1.54B | $1.71B | $477.01M | $929.03M | $618.70M |
| Current assets | — | — | — | — | — | — | — | — | $46.91M | $3.04B | $3.00B | $2.95B | $2.61B | $832.07M | $2.70B | $2.88B | $2.55B | $1.27B | $1.80B | $619.00M |
| Total liabilities | $4.06M | $3.54M | $6.99M | $2.40M | $1.30M | $1.40M | $3.80M | $3.55M | $2.92M | $6.12B | $6.02B | $6.90B | $6.82B | $6.31B | $6.12B | $7.27B | $7.29B | $6.30B | $7.88B | $9.91B |
| Current liabilities | $4.06M | $3.54M | $6.99M | $2.40M | $1.30M | $1.40M | $3.80M | $3.55M | $2.92M | $314.39M | $297.32M | $383.41M | $580.17M | $333.42M | $307.89M | $171.25M | $1.17B | $161.38M | $1.25B | $636.21M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | $6.24B | $5.96B | $5.82B | $7.10B | $6.12B | $6.14B | $6.61B | $8.57B |
| Shareholder equity | $3.79M | $24.06M | $15.61M | $562000.00 | $3.17M | $4.67M | $23.03M | $75.42M | $44.02M | $4.68B | $4.45B | $4.46B | $4.49B | $6.11B | $9.90B | $5.78B | $5.63B | $6.53B | $6.95B | $6.48B |
| Retained earnings | — | — | — | — | — | — | — | — | $-273.06M | $-302.26M | $-319.53M | — | $1.22B | $2.83B | $1.92B | $2.26B | $1.96B | $2.52B | $2.85B | $2.36B |
| Accounts receivable | — | — | — | — | — | — | — | — | — | — | — | — | $198.63M | $38.77M | $39.17M | $68.31M | $36.60M | $22.41M | $26.96M | $883.70M |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | $19.20M | — | $657.14M | $1.00 | $1.00 | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $924.63M |